Zobrazeno 1 - 1
of 1
pro vyhledávání: '"Fawzia Bhatty"'
Autor:
Azita Hajhossein Talasaz, Dave L. Dixon, Fawzia Bhatty, Rachel A. Koenig, Benjamin W. Van Tassell, William L. Baker, Ai-Chen Jane Ho
Publikováno v:
PharmacotherapyREFERENCES. 41(12)
The advent of monoclonal antibodies targeting proprotein convertase subtilisin/kexin type 9 (PCSK9) ushered in a new era of dyslipidemia pharmacotherapy. The first two antibodies targeting PCSK9 (evolocumab, alirocumab) approved by the United States
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c9fe6535379f65c79553919e968b6322
https://pubmed.ncbi.nlm.nih.gov/34657313
https://pubmed.ncbi.nlm.nih.gov/34657313
